Galanin receptor: Difference between revisions
CSV import |
No edit summary Tag: Manual revert |
| (One intermediate revision by the same user not shown) | |
(No difference)
| |
Latest revision as of 17:24, 18 March 2025
Galanin receptor is a type of G protein-coupled receptor that is activated by the neuropeptide galanin. There are three known subtypes of galanin receptors, known as GAL1, GAL2, and GAL3. These receptors are involved in a variety of physiological and pathological processes, including pain regulation, feeding behavior, and mood regulation.
Structure and Function[edit]
Galanin receptors are integral membrane proteins that are composed of seven transmembrane domains. They are coupled to G proteins, which mediate the intracellular responses to galanin binding. The specific responses depend on the subtype of the receptor and the cell type in which it is expressed.
GAL1 is primarily expressed in the central nervous system, and is involved in the regulation of pain and feeding behavior. GAL2 is widely distributed throughout the body and is involved in a variety of functions, including neurotransmission, neuroprotection, and the regulation of mood and cognition. GAL3 is primarily expressed in the peripheral nervous system, and is involved in pain regulation and feeding behavior.
Clinical Significance[edit]
Galanin receptors have been implicated in a variety of diseases and disorders. For example, alterations in galanin receptor function have been associated with neuropathic pain, depression, anxiety, epilepsy, and Alzheimer's disease. As a result, these receptors are being investigated as potential therapeutic targets for these conditions.
Research and Therapeutic Potential[edit]
Research into the function of galanin receptors and the development of drugs that can modulate their activity is an active area of biomedical research. Several compounds that selectively activate or inhibit galanin receptors have been developed, and some of these have shown promise in preclinical studies. However, further research is needed to fully understand the therapeutic potential of these receptors.
See Also[edit]
References[edit]
<references group="" responsive="1"></references>
This GPCR-related article is a stub. You can help WikiMD by expanding it.

This article is a neuroscience stub. You can help WikiMD by expanding it!